MedRx Co., Ltd

4586.T
Drug Manufacturers - Specialty & Generic
2026/08/21 Updated
Market Cap: $27.1M (¥4.3B)
Stock Price: $0.41 (¥65)
Exchange Rate: 1 USD = ¥158.98

Notice of Completion of Payment for the 35th Warrant Carried Out via Third-Party Allotment

Medrexs Corporation completed the payment for the 35th warrants via third-party allotment on June 5, 2026, with potential shares outstanding reaching 14,782,000 shares and funding raised approximately 1,006,584,020 yen.

Importance:
Page Updated: June 5, 2026
IR Disclosure Date: June 5, 2026

Key Figures

  • Potential Shares Outstanding: 14,782,000 shares
  • Funds Raised: approximately 1,006,584,020 yen
  • Number of Warrants: 147,820 units

AI要約

Overview of Capital Policy

Medrexs Corporation completed the issuance and payment for the 35th warrants via third-party allotment on June 5, 2026. The warrants issued numbered 147,820 units, with potential shares outstanding reaching 14,782,000 shares. The exercise price was initially 69 yen, and the exercise period is from June 8, 2026, to June 11, 2027. The funds raised amounted to approximately 1,006,584,020 yen, which are expected to be used for future capital strengthening and business investments.

Impact on Shareholders and Future Outlook

The issuance of these warrants increases potential shares outstanding, which may cause stock dilution risk. However, the funds obtained are expected to support business expansion and R&D promotion. The exercise price is linked to market stock prices and may be adjusted, potentially encouraging exercise depending on stock price movements. Going forward, monitoring exercise status and fund utilization will be essential.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Medrexs Corporation

Company overview · Stock price · Financial data · All IR

View company page →